Generation Bio Co. (GBIO)
After hours:
| Previous Close | 3.4200 |
| Open | 3.5400 |
| Bid | 3.4700 x 400 |
| Ask | 3.5400 x 500 |
| Day's Range | 3.3200 - 3.6500 |
| 52 Week Range | 0.8600 - 5.4960 |
| Volume | |
| Avg. Volume | 159,311 |
| Market Cap | 233.516M |
| Beta (5Y Monthly) | 2.84 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.5500 |
| Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.50 |
GlobeNewswireGeneration Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the virtual 2024 TD Cowen Genetic Medicines & RNA Summit on Friday, June 21st, 2024 at 1:50 p.m. ET. A live webcast of the presentation will be available on the investor section of the company’s
Simply Wall St.Insider Buyers At Generation Bio Sitting On US$1.1m Profit
Insiders who bought Generation Bio Co. ( NASDAQ:GBIO ) in the last 12 months may probably not pay attention to the...
ZacksGeneration Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
Generation Bio (GBIO) delivered earnings and revenue surprises of -211.11% and 34.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
